… This study aims to evaluate the efficacy of tocilizumab (in terms of mortality rates) in
COVID-19 patients with pneumonia and uses posology ranging from 8 mg/kg up to 800 mg (possibly …

… to administer low-dose tocilizumab to hospitalized patients with COVID-19. We present
the … evidence of low-dose tocilizumab activity in hospitalized patients with COVID-19–associated …

… trial of low-dose tocilizumab in hospitalized adult patients with Covid-19, … Dose cohorts were
determined by a trial Operations … A range of doses from 40 to 200 mg (low-dose tocilizumab) …

… paper, we describe 158 patients with COVID-19, ninety of whom were treated early in the
disease course with single - low dose of tocilizumab. Our a priori hypothesis was twofold. First, …

… Single-centre nonrandomized observational study (USA) ICU patients with critical COVID-19
(n = 60) 400 mg flat dosing of tocilizumab with possible redosing based on clinical …

… [33] In a retrospective study conducted by Alattar and colleagues in Qatar, 25 patients with
COVID-19 received one to three median doses 4.8 mg/kg. Result of this study showed that …

… and ARDS requiring ventilatory support in Brescia (Italy), in which tocilizumab was administered
at a dosage of 8 mg/kg using two consecutive intravenous infusions 12 h apart, and an …

Treatment of acute respiratory distress syndrome (ARDS) due to COVID-19 pneumonia (…
antibody tocilizumab (TCZ). We reported the case of a 54-year-old 100 kg male COVID-19 …

… doses of TCZ is recommended for critically ill COVID-19 … -IL-6 receptor antibody TCZ in
COVID-19 patients is based on our … The present study suggested that a single dose of TCZ seems …

… efficacy profile of low-dose tocilizumab (TCZ), to prevent disease progression, subcutaneously
administered to patients with moderate COVID-19 pneumonia and hyperinflammation. …